EBMT NEWSLETTER | July 2015 | Volume 47 - Issue 2

EBMT
Important dates
Bone Marrow Transplantation publishes high quality, peer reviewed original research and reviews that address all aspects of basic biology and clinical use of haemopoietic cell transplantation.
The journal also covers all aspects of the research and treatment of transplant-related complications and consequences including quality of life and psychological issues. Basic research studies on topics of relevance are also covered.
The broad scope of the journal encompasses topics such as stem cell biology, transplantation immunology (including animal models), translational research, biomarkers, cellular therapy, and clinical results of specific protocols.
 
2014 Impact Factor 3.570*
19/68 Hematology
55/144 Immunology
69/203 Oncology
8/25 Transplantation
 
*2014 Journal Citation Reports® Science Edition (Thomson Reuters, 2015)
 
Average time to first decision = 10 days
Average time to online publication  = 24 days
Open Access option
High visibility via nature.com

Have you read the below recently trending articles… 

Allogeneic hematopoietic cell transplantation for myelofibrosis inpatients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib
Jaekel, N.; Behre, G.; Behning, A.; et al.
 
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease
Bhatia, M.; Jin, Z.; Baker, C.; et al.
 
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
Baron, F.; Labopin, M.; Blaise, D.; et al.
 
Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation
Marsh, J. C.; Pearce, R. M.; Koh, M. B. C.; et al.
 
Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma
Raiola, A.; Dominietto, A.; Varaldo, R.; et al.
 
Hematopoietic SCT in Europe: data and trends in 2012 with specialconsideration of pediatric transplantation 
Passweg, J. R.; Baldomero, H.; Peters, C.; et al.
 
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation
Gilis, L.; Morisset, S.; Billaud, G.; et al.
 
 Submit to BMT 
Bookmark and Share